SCHEMBL28239683

SCHEMBL28239683

B.COc1ccccc1C(=O)NC(F)[K]

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.60
ALDH1A1 P00352 1/20 0.60
CTSD P07339 1/20 0.57
NPC1 O15118 3/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
STAT3 P40763 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
RAB9A P51151 4/20 0.53
GAA P10253 2/20 0.52
KCNK3 O14649 2/20 0.51
KCNK9 Q9NPC2 2/20 0.51
TSHR P16473 2/20 0.50
LMNA P02545 2/20 0.50
MAPT P10636 1/20 0.50
MAPK1 P28482 1/20 0.50
HSD17B10 Q99714 1/20 0.50
RXFP1 Q9HBX9 1/20 0.50
TP53 P04637 1/20 0.50
GLA P06280 1/20 0.50
PKM P14618 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28983001 0.83 HPGD (0.61) HPGDALDH1A1CTSDNPC1SMN1; SMN2
SCHEMBL18893131 0.82 L3MBTL1 (0.74) HPGDALDH1A1CTSDNPC1SMN1; SMN2
SCHEMBL30848409 0.81 HPGD (0.64) HPGDALDH1A1CTSDNPC1SMN1; SMN2
SCHEMBL8029750 0.79 HPGD (0.69) HPGDALDH1A1CTSDNPC1SMN1; SMN2
SCHEMBL24801412 0.78 HPGD (0.68) HPGDALDH1A1CTSDNPC1SMN1; SMN2
SCHEMBL24568217 0.78 HPGD (0.68) HPGDALDH1A1CTSDNPC1SMN1; SMN2
Alcohol SCHEMBL6836623 0.78 L3MBTL1 (0.68) HPGDALDH1A1CTSDNPC1SMN1; SMN2
SCHEMBL528651 0.76 CTSD (0.68) HPGDALDH1A1CTSDNPC1SMN1; SMN2
SCHEMBL2251625 0.76 HPGD (0.70) HPGDALDH1A1CTSDNPC1SMN1; SMN2
SCHEMBL2251629 0.76 HPGD (0.70) HPGDALDH1A1CTSDNPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108431007-A PYRAZOLOPYRIMIDINE DERIVATIVES AS BTK INHIBITORS FOR THE TREATMENT OF CANCER 洛克索肿瘤学股份有限公司 2018-08-21 CN disclosed